SOURCE: ZELTIQ Aesthetics, Inc.

January 13, 2015 20:10 ET

ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference

Investor Presentation Now Available on Corporate Website

PLEASANTON, CA--(Marketwired - Jan 13, 2015) - ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, CoolSculpting®, will present at the J.P. Morgan 33rd Annual Healthcare Conference tomorrow, Wednesday, January 14, 2015. President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PT / 10:30 a.m. ET at the Westin St. Francis Hotel in San Francisco. A copy of ZELTIQ's investor presentation is available on the investor relations section of ZELTIQ's web site, at www.coolsculpting.com.

In anticipation of the event, the Company has posted its investor presentation under the Investor Relations section of ZELTIQ's website at www.zeltiq.com. An audio webcast of the Company's presentation will be available by visiting the investor relations web site. A replay of the presentation will be available for 90 days.

About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.